Home
News Open submenu
About MedNous Open submenu
Research Directory Open submenu
Contact Us Open submenu

Close submenu News

News
Appointments
Events

Close submenu About MedNous

Who We Are
Editorial Board
Editorial Policy

Close submenu Research Directory

Research Directory
Organisations
Interviewees
Terms
Topics

Close submenu Contact Us

Contact Form

Skip to main content

28 May 2025

Last updated: Sunday 25 May 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Why the time has come for MidPharmas

Sunday 2 March 2014

Interviewee/Contributor

John Rountree

Organisation

Novasecta

Pagination

First page
Previous page
Page 1
Current page 2

Organisations

Anavo Therapeutics BV
Kilburn & Strode
German Pharmaceutical Industry Association
Immune Targeting Systems Ltd
London Business School
Genmab A/S
Abingworth LLP
Leyden Laboratories BV
European Forum for Good Clinical Practice
European patent and trade mark attorney

Interviewees and Contributers

Douglas Melton
Rafiq Hasan
Wolfgang Kintzel
Herve Brailly
Stephen J Turner
Marisa Papaluca-Amati
Andrew Hopkins
Steven D. Pearson
Harren Jhoti
Alastair Smith

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.